These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 386519)

  • 61. Prostaglandins and platelets.
    Mustard JF; Kinlough-Rathbone RL; Packham MA
    Annu Rev Med; 1980; 31():89-96. PubMed ID: 6994628
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Platelet aggregation induced by antilymphocyte serum. I. Differences between washed and unwashed platelets.
    Hussey CV; Wang TY; Garancis JC; Fobian JE
    Am J Clin Pathol; 1975 Nov; 64(5):580-90. PubMed ID: 811109
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.
    Moncada S; Vane JR
    Br Med Bull; 1978 May; 34(2):129-35. PubMed ID: 350335
    [No Abstract]   [Full Text] [Related]  

  • 64. Potentiating effects of clofibrate on prostaglandin-dependent and -independent pathways of human platelet activation: evidence for involvement of cyclic AMP.
    Huzoor-Akbar ; Witiak DT; Newman HA; Fertel RH; Feller DR
    Biochem Pharmacol; 1982 Jun; 31(11):2125-8. PubMed ID: 6288050
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141) on rabbit platelet aggregation in vitro and rat platelet retention.
    Umetsu T; Kato T
    Thromb Haemost; 1978 Feb; 39(1):167-76. PubMed ID: 580491
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
    Mehta J; Mehta P; Hay D
    Prostaglandins; 1982 Dec; 24(6):751-61. PubMed ID: 6820166
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Does the association dipyridamole-aspirin only act by a functional synergism?
    De la Cruz JP; Sanchez de la Cuesta F
    Gen Pharmacol; 1991; 22(2):271-4. PubMed ID: 2055420
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug influence on platelet loss during extracorporeal circulation.
    Mielke CH; de Leval M; Hill JD; Macur MF; Gerbode F
    J Thorac Cardiovasc Surg; 1973 Dec; 66(6):845-54. PubMed ID: 4759692
    [No Abstract]   [Full Text] [Related]  

  • 69. Effect of nabumetone (BRL 14777), a new anti-inflammatory drug, on human platelet reactivity ex vivo: comparison with naproxen.
    Nunn B; Chamberlain PD
    J Pharm Pharmacol; 1982 Sep; 34(9):576-9. PubMed ID: 6127382
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acetylenic analog of arachidonate that acts like aspirin on platelets.
    Willis AL; Kuhn DC; Weiss HJ
    Science; 1974 Jan; 183(4122):327-30. PubMed ID: 4809077
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
    Bouvier CA
    Ther Umsch; 1974 Feb; 31(2):84-8. PubMed ID: 4612856
    [No Abstract]   [Full Text] [Related]  

  • 72. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
    Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
    Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
    [No Abstract]   [Full Text] [Related]  

  • 73. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 74. Platelet aggregation and haemolysis induced in rats by intravenous infusion of ADP - effect of potentially antithrombotic drugs.
    Reyers-Degli Innocenti I; Poggi A; de Gaetano G
    Scand J Haematol; 1974; 13(5):331-7. PubMed ID: 4616330
    [No Abstract]   [Full Text] [Related]  

  • 75. Influence of some drugs on platelet aggregation: a study in hypertensive patients.
    Bologna E
    Acta Univ Carol Med Monogr; 1972; 52():87-92. PubMed ID: 4669830
    [No Abstract]   [Full Text] [Related]  

  • 76. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of dipyridamol on the electrokinetic potential of platelets.
    Aznar J; Vallés J
    Rev Esp Fisiol; 1974 Jun; 30(2):77-9. PubMed ID: 4278529
    [No Abstract]   [Full Text] [Related]  

  • 78. Proceedings: Response of normal and pathological platelets to heparin added in vitrio and in vivo.
    David JL; Herion FP
    Thromb Diath Haemorrh; 1975 Sep; 34(1):341. PubMed ID: 1188778
    [No Abstract]   [Full Text] [Related]  

  • 79. The effect of PGI2 and PGI2 analogues with increased stability on platelet cAMP content and aggregation.
    Blaskó G; Nemesánszky E; Szabó G; Stadler I; Pálos LA
    Thromb Res; 1980 Mar; 17(5):673-81. PubMed ID: 6247777
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical application of platelet aggregation.
    Attar S; McLaughlin JS; Masaitis C
    South Med J; 1973 Apr; 66(4):481-5. PubMed ID: 4708247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.